MedEvoke Strengthens Clinical and Creative Divisions With Prominent Hires
MedEvoke, an industry leader in Global Alignment, amplifies its creative team with a pharma MM&M Top 100 Agency award-winning leader, and adds weight to its growing clinical content team by adding a doctoral specialist in gene therapy that will help increase awareness in this breakthrough area of research.
HIGH BRIDGE, N.J., March 14, 2019 (Newswire.com) - An industry leader in Global Alignment, MedEvoke is uniquely focused on developing consistent, scientifically-compelling narratives and digitally-oriented solutions tailored to meet clients’ needs worldwide. Today, the company amplifies its creative team with a pharma MM&M Top 100 Agency award-winning leader, and adds weight to its growing clinical content team by adding a doctoral specialist in gene therapy that will help increase awareness in this breakthrough area of research.
Rich Miller has been hired as Chief Creative Officer. With over 25 years of experience, Rich is renowned for driving new business, building dynamic teams, and generating award-winning solutions. Previously he was Vice President, Creative Director at Bionical Solutions and Vice President, Creative Director at Artcraft Health. Producing dynamic work for such notable clients as Pfizer, Novartis, Celgene, Astra Zeneca, Merck, and others, his span of therapeutic areas has been multi-dimensional in the Oncology, Endocrinology Immunology, and Pulmonology categories, as well as the Clinical Trial and Medical Device categories. Throughout his career, distinctions have included the MM&M Gold, PM360 Trailblazer, Pharma Choice Gold, New Jersey Ad Club, Interactive Media, Marcom Platinum, Communicator Award of Excellence, Graphic Design USA, and Hermes Gold Awards. Goals for his new position are to bring further innovation and excellence to the growing MedEvoke team.
From the ground up, first with content that our clients are continually seeking insights into in the gene therapy category, and ultimately extending to branding for our clients. I'm excited to welcome them and can't wait to see the impact for our clients over time.
Marc Sirockman, President
In addition, Jayme Warischalk, Ph.D., has been hired as a Medical Writer. Jayme has a strong scientific background, having earned a Ph.D. in Pharmacology from the University of North Carolina and an MS in Biochemistry and Biophysics from the University of Pennsylvania. She has broad knowledge of gene therapeutics, for which she was awarded a patent for improving the delivery of adeno-associated virus (AAV) to skeletal and cardiac muscle to enhance the clinical application of gene therapy for diseases such as muscular dystrophy and heart failure. Most recently, she worked as a scientific video script writer for diverse audiences. Jayme also holds BS degrees in Mathematics, Chemistry, and Biology from the University of Tampa.
Of these two key additions to its staff, Marc Sirockman, President of MedEvoke, suggests that each will help to galvanize the entire MedEvoke team in vital new ways “from the ground up, first with content that our clients are continually seeking insights into in the gene therapy category, and ultimately extending to branding for our clients. I’m excited to welcome them and can’t wait to see the impact for our clients over time.”
As a premier solutions provider for over two decades, MedEvoke specializes in data analysis, cross-functional engagement, and seamless evolution of narrative – and offers its clients a real-time single-source platform that shares “one medical voice” throughout their products’ lifecycles. Expertise ranges from single product launches to life-cycle management to enterprise/portfolio solutions in varied therapeutic categories.
Marc Sirockman
msirockman@medevoke.com
908.240.8399
# # #
Share:
Tags: Clinical Trials, Global Alignment, GlobalEngagement, Healthcare, HealthcareOptimization, MedEvoke, MedicalAffairs, MedicalCommunications, NewHires, Pharmaceuticals, StrategicPartner
